Pharmacology and Drug Development: From Discovery to Market

Drug Discovery

Target Profile – Intended therapeutic site of action and clinical outcome

Lead Identification – Identified candidate compounds with potential drug activity commensurate with profile from a library of actives (hits)

Lead Optimization – Identification / modification of lead compounds for best action / least side effects, etc.

Combinatorial Chemistry – Generation of active compounds (hits) from a library of building blocks

Structure-Activity Relationship – Determination of the relationship

Read More

Human Genome and Bioethics: Implications and Risks

The Human Genome: Our Book of Instructions

The human genome is the set of all genes in our species, distributed across 23 pairs of chromosomes in our cells. Their study is the field of genomics. Beginning in 1990, the Human Genome Project was designed to locate and study the function of genes. The human genome contains approximately 35,000 genes. Almost 25% of the genome is deserted, and genes are not regularly scattered across chromosomes. Only 5% of human DNA contains genes, the carriers of instructions

Read More

Toxicology: Antidotes, Elimination, and Chemical Analysis

Antidote Treatments

The objective is to neutralize toxins absorbed into the blood and tissues.

Types of Antidotes

  • Chemical Antidotes: These convert a toxic substance into a non-toxic compound. For example, glucose + CnH = Heptose, and sodium thiosulphate + metal = sulfur compounds.
  • Chelating Agents: These compounds combine with metals and metalloids, forming water-soluble, nonionic chelates that are usually less toxic or non-toxic. Examples include BAL for As, Hg, Cr, Au; and Cobalt EDTA for Cyanides.
Read More

Oncogenes, Tumor Suppressor Genes, and DNA Repair: Cancer Development

Oncogenes, Tumor Suppressor Genes, and DNA Repair Genes

Oncogenes

Oncogenes are altered (mutated) versions of normal genes that can promote malignant transformation. Normal genes, when not mutated, are called proto-oncogenes and usually promote growth. They can be growth factors, growth factor receptors, plasma kinases, or transcription factors. Oncogenes are a group of damaged genes involved in cancer development. Their presence, overactivity, or both, can stimulate cancer development. When oncogenes

Read More

Recombinant DNA Technology: Methods and Applications

Restriction Enzymes

Saccharomyces cerevisiae plays a crucial role in recombinant DNA technology. This process involves coding sequences and regulatory elements. Restriction endonucleases, bacterial enzymes capable of cutting DNA, are fundamental. They recognize specific palindromic sequences, producing either blunt or cohesive ends. DNA fragments are then separated by gel electrophoresis, using agarose or polyacrylamide gels.

Plasmids and DNA Ligases

Plasmids, bacterial or viral genomes, and artificially

Read More

DNA Recombination, Biotechnology, and Genetic Engineering

DNA Recombination

DNA recombination is a process that allows the combination of DNA fragments from different origins. This can be done in a laboratory using cellular machinery and enzymes. DNA can be cut into fragments using enzymes called restriction endonucleases. The resulting fragments have cohesive or sticky edges complementary to other DNA cut with the same enzyme, so you can join different fragments of recombinant DNA origin. In this way, it is possible to introduce DNA into the genome of

Read More